Wednesday, October 20, 2010

Google Alert - health

News8 new results for health
 
Study: Cancer care standards not met
Chicago Tribune
A patient at Mt. Sinai Hospital in Chicago meets with doctors this month as she decides whether to have a lumpectomy or mastectomy after her breast cancer diagnosis. (Nancy Stone/Tribune) By Deborah L. Shelton, Tribune reporter Many Chicago-area ...
See all stories on this topic »
4 Baby Deaths Spur Graco Stroller Recall
WebMD
By Daniel J. DeNoon Oct. 20, 2010 -- The strangulation deaths of four babies has led Graco to recall 2 million Quattro and MetroLite brand strollers. The deaths aren't recent. They occurred between 2003 and 2005. That bothers Donald Mays, ...
See all stories on this topic »

WebMD
Highest teen birthrates are in the South
Los Angeles Times
A CDC study finds a slight dip in the overall teen birthrate to 41.5 births per 1000, with the highest rate, 65.7, seen in the state of Mississippi. The lowest are in the northeast. The highest teenage birthrates in the US are clustered in Southern ...
See all stories on this topic »
NC girl's stepsister: Don't free my mother
The Herald | HeraldOnline.com
By Franco Ordoñez and Steve Lyttle - fordonez@charlotteobserver.com Zahra Baker's stepsister asked a judge Wednesday not to release her mother from jail, saying she feared for her safety and that of her own children. Amber Fairchild, 25, described her ...
See all stories on this topic »

The Herald | HeraldOnline.com
No Benefit of DHA Fish Oil for Postpartum Depression, Child Neurodevelopment
Medscape
October 20, 2010 — Fish oil capsules enhanced with docosahexaenoic acid (DHA) and given to women during pregnancy do not decrease postpartum depression or improve neurodevelopment in the women's offspring compared with vegetable oil capsules, ...
See all stories on this topic »
Moody's reviews Eli Lilly's rating for downgrade
BusinessWeek
Ratings service Moody's Investors Service said Wednesday it has placed the A1 long-term rating of Eli Lilly and Co. under review for possible downgrade, following a setback with a new diabetes treatment. The action comes one day before the company ...
See all stories on this topic »
FDA: Prostate Cancer Drugs Raise Diabetes, Heart Risk
WebMD
By Daniel J. DeNoon Oct. 20, 2010 -- A class of drugs used to treat advanced prostate cancer raise patients' risk of diabetes, heart disease, and stroke, the FDA today warned. The five drugs, gonadotropin-releasing hormone (GnRH) agonists, are approved ...
See all stories on this topic »
Dollars for Docs - Big Pharma & Physicians
Nightly Business Report
SUSIE GHARIB: Does your doctor take money from drug companies to speak on their behalf? If he or she does, it`s been a closely kept industry secret, until now. The non-profit newsroom Propublica has developed a database of payments to thousands of ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment